Europe Renal Denervation Market Size, Share & Industry Trends Analysis Report By Technology (Radiofrequency, Ultrasound, and Micro-Infusion), By End User, By Product Type By Country and Growth Forecast, 2022 - 2028

Europe Renal Denervation Market Size, Share & Industry Trends Analysis Report By Technology (Radiofrequency, Ultrasound, and Micro-Infusion), By End User, By Product Type By Country and Growth Forecast, 2022 - 2028

The Europe Renal Denervation Market would witness market growth of 35.5% CAGR during the forecast period (2022-2028).

Renal denervation minimally invasive operation is proving to be a promising new non-drug treatment option for controlling blood pressure in individuals with resistant hypertension, however, long-term blood pressure control effects of renal denervation for resistant hypertension have yet to be evaluated. Various market players are focusing on analyzing current long-term follow-up data on the use of renal denervation for RH in order to completely examine the efficiency of renal denervation for RH and to provide practical assistance for practitioners who are setting up a renal denervation service. Moreover, ambulatory blood pressure is a preferred choice for blood pressure measurement.

According to Public Health England data, more than one in every four people in England has high blood pressure. Additionally, as per the data shared by the NHS Digital from the 2019 Health Survey for England, the proportion of males with hypertension grew from 28% to 30% between 2017 and 2018, while rates for women increased from 25% to 26%. Two-thirds of males aged 75 and up have hypertension of some kind. Lack of physical activity, excessive alcohol intake, smoking, and fast food consumption all contribute to an increased risk of hypertension. In addition, various disorders, such as heart attacks, stroke, and pulmonary arterial hypertension, can be caused by high blood pressure.

CE approval has been granted to a significant number of renal denervation devices across the region. Growing R&D initiatives to produce efficient gadgets are a major driver driving the market's growth. The introduction of new items in the region would also help the industry to flourish. Rising incidences of drug-resistant hypertension can increase the growth of the market throughout the forecasting years.

The Germany market dominated the Europe Renal Denervation Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $92.4 million by 2028. The UK market is poised to grow at a CAGR of 34.4% during (2022 - 2028). Additionally, The France market would witness a CAGR of 36.5% during (2022 - 2028).

Based on Technology, the market is segmented into Radiofrequency, Ultrasound, and Micro-Infusion. Based on End User, the market is segmented into Hospitals, Specialty Clinics, and Others. Based on Product Type, the market is segmented into Symplicity, Enlightn, Vessix, Paradise, Iberis, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC, Ablative Solutions, Inc., Mercator MedSystems, Inc., ReCor Medical, Inc., Renal Dynamics Limited, Johnson & Johnson, and Terumo Corporation.

Scope of the Study

Market Segments covered in the Report:

By Technology

  • Radiofrequency
  • Ultrasound
  • Micro-Infusion
By End User
  • Hospitals
  • Specialty Clinics
  • Others
By Product Type
  • Symplicity
  • Enlightn
  • Vessix
  • Paradise
  • Iberis
  • Others
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Companies Profiled
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Medtronic PLC
  • Ablative Solutions, Inc.
  • Mercator MedSystems, Inc.
  • ReCor Medical, Inc.
  • Renal Dynamics Limited
  • Johnson & Johnson
  • Terumo Corporation
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Renal Denervation Market, by Technology
1.4.2 Europe Renal Denervation Market, by End User
1.4.3 Europe Renal Denervation Market, by Product Type
1.4.4 Europe Renal Denervation Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Renal Denervation Market by Technology
3.1 Europe Radiofrequency Market by Country
3.2 Europe Ultrasound Market by Country
3.3 Europe Micro-Infusion Market by Country
Chapter 4. Europe Renal Denervation Market by End User
4.1 Europe Hospitals Market by Country
4.2 Europe Specialty Clinics Market by Country
4.3 Europe Others Market by Country
Chapter 5. Europe Renal Denervation Market by Product Type
5.1 Europe Symplicity Market by Country
5.2 Europe Enlightn Market by Country
5.3 Europe Vessix Market by Country
5.4 Europe Paradise Market by Country
5.5 Europe Iberis Market by Country
5.6 Europe Others Market by Country
Chapter 6. Europe Renal Denervation Market by Country
6.1 Germany Renal Denervation Market
6.1.1 Germany Renal Denervation Market by Technology
6.1.2 Germany Renal Denervation Market by End User
6.1.3 Germany Renal Denervation Market by Product Type
6.2 UK Renal Denervation Market
6.2.1 UK Renal Denervation Market by Technology
6.2.2 UK Renal Denervation Market by End User
6.2.3 UK Renal Denervation Market by Product Type
6.3 France Renal Denervation Market
6.3.1 France Renal Denervation Market by Technology
6.3.2 France Renal Denervation Market by End User
6.3.3 France Renal Denervation Market by Product Type
6.4 Russia Renal Denervation Market
6.4.1 Russia Renal Denervation Market by Technology
6.4.2 Russia Renal Denervation Market by End User
6.4.3 Russia Renal Denervation Market by Product Type
6.5 Spain Renal Denervation Market
6.5.1 Spain Renal Denervation Market by Technology
6.5.2 Spain Renal Denervation Market by End User
6.5.3 Spain Renal Denervation Market by Product Type
6.6 Italy Renal Denervation Market
6.6.1 Italy Renal Denervation Market by Technology
6.6.2 Italy Renal Denervation Market by End User
6.6.3 Italy Renal Denervation Market by Product Type
6.7 Rest of Europe Renal Denervation Market
6.7.1 Rest of Europe Renal Denervation Market by Technology
6.7.2 Rest of Europe Renal Denervation Market by End User
6.7.3 Rest of Europe Renal Denervation Market by Product Type
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.2 Boston Scientific Corporation
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.3 Medtronic PLC
7.3.1 Company overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Partnerships, Collaborations, and Agreements:
7.4 Ablative Solutions, Inc.
7.4.1 Company Overview
7.5 Mercator MedSystems, Inc.
7.5.1 Company Overview
7.6 ReCor Medical, Inc (Otsuka Holdings Co., Ltd.)
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments:
7.6.5.1 Product Launches and Product Expansions:
7.7 Renal Dynamics Limited
7.7.1 Company Overview
7.8 Johnson & Johnson
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental &Regional Analysis
7.8.4 Research & Development Expenses
7.8.5 Recent strategies and developments:
7.8.5.1 Partnerships, Collaborations and Agreements:
7.9 Terumo Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental Analysis
7.9.4 Recent strategies and developments:
7.9.4.1 Acquisition and Mergers:

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings